Marksans Pharma's Goa unit clears USFDA inspection

Last Updated : Nov 10 2025 | 2:31 PM IST

Marksans Pharma announced that a current Good Manufacturing Practice (cGMP) inspection was conducted by the US FDA at the 2nd manufacturing facility of the Company located at Plot No. A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa, India from 3rd November 2025 to 7th November 2025.

The said inspection concluded with Zero Form 483 observation.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

Benchmarks trade higher; European mrkt advance

Wework India Management consolidated net profit declines 96.91% in the September 2025 quarter

Investment & Precision Castings consolidated net profit rises 96.75% in the September 2025 quarter

Celebrity Fashions reports standalone net loss of Rs 3.95 crore in the September 2025 quarter

Gujarat State Financial Corporation reports standalone net loss of Rs 31.96 crore in the September 2025 quarter

First Published: Nov 10 2025 | 2:08 PM IST